GO:0032476 polyprenyl diphosphate synthase complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032476 (polyprenyl diphosphate synthase complex) is a cellular component defined as a complex that possesses polyprenyl diphosphate synthase activity involved in the synthesis of the isoprenoid chain of ubiquinone, whose length varies between organisms.
• The complex is best characterized in bacteria, yeast and fission yeast, where it can be homo- or heteromeric; in Escherichia coli, a subunit of decaprenyl diphosphate synthase stabilizes octaprenyl diphosphate synthase by forming a high-molecular-weight complex.
• In Saccharomyces cerevisiae, genetic evidence supports a multi-subunit complex in coenzyme Q biosynthesis, with Coq1 as the hexaprenyl diphosphate synthase.
• In Schizosaccharomyces pombe, decaprenyl diphosphate synthase is a heterotetramer composed of Dps1 and the newly characterized Dlp1 protein.
• In Mycobacterium tuberculosis, decaprenyl diphosphate synthesis is essential for the isoprenoid chain of ubiquinone, and the responsible enzyme is a validated target for anti-tubercular research.
• The complex is a tractable model for studying isoprenoid chain-length control, protein-protein stabilization, and ubiquinone biosynthesis, with relevance to mitochondrial disease, bacterial pathogenesis and metabolic engineering [1,6].
Description
GO:0032476, polyprenyl diphosphate synthase complex, is a cellular component term that describes the enzymatic machinery responsible for producing the polyprenyl diphosphate isoprenoid chain used in ubiquinone (coenzyme Q) biosynthesis [5,7]. The length of this isoprenoid chain varies between organisms, from six isoprene units in some yeasts to ten in humans and mycobacteria, and this variation is dictated by the subunit composition and catalytic properties of the complex [5,7,8]. Because ubiquinone is a central electron carrier in respiratory chains and a lipophilic antioxidant, the polyprenyl diphosphate synthase complex sits at the intersection of energy metabolism, oxidative stress defense and mitochondrial function [1,5]. Researchers study GO:0032476 to understand how cells build the hydrophobic tail of ubiquinone, how protein-protein interactions stabilize labile prenyltransferases, and how chain length is controlled across species [2,5,8]. In bacteria such as Escherichia coli, a subunit of decaprenyl diphosphate synthase stabilizes octaprenyl diphosphate synthase by forming a high-molecular-weight complex, illustrating that complex assembly can regulate enzyme abundance and activity. In fission yeast, decaprenyl diphosphate synthase consists of Dps1 and Dlp1 in a novel heterotetrameric structure, providing a genetically tractable model for subunit function. In Mycobacterium tuberculosis, decaprenyl diphosphate synthesis is required for ubiquinone production and has been explored as a drug target. The term is also relevant to human health because ubiquinone deficiency and mitochondrial dysfunction underlie a spectrum of disorders, including Leigh syndrome spectrum presentations. Metabolic engineering efforts in Corynebacterium glutamicum have rationally modified non-ubiquinone-containing strains to enhance coenzyme Q10 production, directly leveraging knowledge of polyprenyl diphosphate synthase complexes. Thus, GO:0032476 connects fundamental enzymology, microbial genetics and translational research.
polyprenyl diphosphate synthase complex At A Glance
| GO ID | GO:0032476 |
|---|---|
| GO term | polyprenyl diphosphate synthase complex |
| Ontology | cellular_component |
| Synonym | decaprenyl diphosphate synthase complex |
| Major function | Synthesis of the isoprenoid chain of ubiquinone (coenzyme Q) |
| Chain length | Varies between organisms (e.g., hexaprenyl in some yeasts, octaprenyl in E. coli, decaprenyl in humans and M. tuberculosis) |
| Subunit architecture | Homo- or heteromeric; examples include a heterotetramer in S. pombe and a multi-subunit complex in S. cerevisiae |
| Representative organisms | Escherichia coli, Saccharomyces cerevisiae, Schizosaccharomyces pombe, Mycobacterium tuberculosis, Corynebacterium glutamicum |
| Related pathway | Ubiquinone (coenzyme Q) biosynthesis |
What Is GO:0032476?
In simple terms, GO:0032476 describes a protein complex whose job is to build the long isoprenoid tail of ubiquinone. According to the QuickGO definition, it is a complex that possesses polyprenyl diphosphate synthase activity involved in the synthesis of the isoprenoid chain of ubiquinone, and the length of that chain varies between organisms. The synonym decaprenyl diphosphate synthase complex reflects the common case in which the complex produces a ten-isoprene-unit chain, as seen in humans and Mycobacterium tuberculosis [7,8].
Why Is polyprenyl diphosphate synthase complex Important in Cell Biology?
The polyprenyl diphosphate synthase complex is important because it produces the polyprenyl diphosphate substrate that defines the length and physicochemical properties of ubiquinone, a molecule essential for mitochondrial and bacterial respiratory electron transport and for protection against oxidative stress [1,5]. Defects in ubiquinone biosynthesis, including steps upstream of or within the polyprenyl diphosphate synthase complex, can cause mitochondrial disease presentations such as Leigh syndrome spectrum. In pathogens like Mycobacterium tuberculosis, decaprenyl diphosphate synthesis is required for ubiquinone production, making the complex a potential antibacterial target. In biotechnology, engineering of polyprenyl diphosphate synthase complexes has been used to enhance coenzyme Q10 production in Corynebacterium glutamicum. Understanding the assembly and regulation of this complex therefore has direct implications for human health, infectious disease and industrial biosynthesis.
• Provides the polyprenyl diphosphate tail required for ubiquinone (coenzyme Q) biosynthesis [5,7].
• Determines the isoprenoid chain length of ubiquinone, which varies between organisms [5,7,8].
• Supports mitochondrial and bacterial respiratory electron transport through ubiquinone production [1,5].
• Contributes to oxidative stress defense via ubiquinone and its reduced form.
• Is linked to mitochondrial disease, including Leigh syndrome spectrum presentations.
• Represents a potential antibacterial target in Mycobacterium tuberculosis.
• Serves as a model for protein-protein stabilization of labile prenyltransferases.
• Is a target for metabolic engineering of coenzyme Q10 production.
• Enables comparative evolutionary studies of trans-isoprenyl diphosphate synthases across kingdoms.
• Provides genetically tractable systems in yeasts for dissecting subunit function [5,8].
Structure and Composition of polyprenyl diphosphate synthase complex
Heterotetrameric architecture in fission yeast
In simple terms: In fission yeast, the complex is built from two different proteins that come together in a four-part arrangement.
In Schizosaccharomyces pombe, decaprenyl diphosphate synthase consists of Dps1 and the newly characterized Dlp1 protein in a novel heterotetrameric structure. This heterotetrameric organization distinguishes the fission yeast enzyme from simpler homodimeric prenyltransferases and provides a genetically tractable system for assigning functions to individual subunits.
Multi-subunit complex in budding yeast
In simple terms: In budding yeast, coenzyme Q biosynthesis requires several proteins working together, with Coq1 as the enzyme that builds the prenyl tail.
Genetic evidence in Saccharomyces cerevisiae supports a multi-subunit complex in coenzyme Q biosynthesis, in which Coq1 functions as the hexaprenyl diphosphate synthase. This work established that polyprenyl diphosphate synthase activity is not necessarily carried by a single isolated enzyme but can be part of a larger biosynthetic assembly.
Subunit stabilization in Escherichia coli
In simple terms: In E. coli, one protein helps stabilize another prenyltransferase by forming a larger complex with it.
A subunit of decaprenyl diphosphate synthase stabilizes octaprenyl diphosphate synthase in Escherichia coli by forming a high-molecular-weight complex. This observation indicates that complex formation can regulate the stability and abundance of polyprenyl diphosphate synthase components, adding a layer of post-translational control.
Decaprenyl diphosphate synthesis in Mycobacterium tuberculosis
In simple terms: In the tuberculosis bacterium, the complex makes a ten-unit prenyl chain that is used to build ubiquinone.
Decaprenyl diphosphate synthesis in Mycobacterium tuberculosis has been characterized, and the responsible enzyme produces the decaprenyl chain used in ubiquinone biosynthesis. Because this pathway is essential in mycobacteria, the polyprenyl diphosphate synthase complex is of interest as a target for anti-tubercular drug discovery.
Evolutionary diversity of trans-isoprenyl diphosphate synthases
In simple terms: Across plants and other organisms, the enzymes that make prenyl chains have diversified over evolution.
Evolution of trans-isoprenyl diphosphate synthases in the plant kingdom has been analyzed, revealing diversification of these enzymes across species. Evolutionary divergence and functional insights into heteromeric cis-prenyltransferases have also been reported in Paramecium tetraurelia, highlighting that prenyltransferase complexes can adopt diverse subunit compositions. These comparative studies help explain why the isoprenoid chain length of ubiquinone varies between organisms [3,4].
Key Genes Involved in GO:0032476 polyprenyl diphosphate synthase complex
The following genes and proteins are experimentally implicated in the composition, function or study of the polyprenyl diphosphate synthase complex (GO:0032476).
| Gene | Major Role | Research Relevance |
|---|---|---|
| Coq1 (S. cerevisiae) | Hexaprenyl diphosphate synthase in coenzyme Q biosynthesis | Genetic evidence for a multi-subunit complex in yeast |
| Dps1 (S. pombe) | Subunit of decaprenyl diphosphate synthase | Forms a heterotetramer with Dlp1 |
| Dlp1 (S. pombe) | Newly characterized subunit of decaprenyl diphosphate synthase | Required for heterotetrameric structure and function |
| E. coli decaprenyl diphosphate synthase subunit | Stabilizes octaprenyl diphosphate synthase | High-molecular-weight complex formation |
| E. coli octaprenyl diphosphate synthase | Produces octaprenyl diphosphate for ubiquinone | Stabilized by decaprenyl diphosphate synthase subunit |
| M. tuberculosis decaprenyl diphosphate synthase | Produces decaprenyl diphosphate for ubiquinone | Potential anti-tubercular target |
| C. glutamicum prenyltransferase genes | Coenzyme Q10 biosynthesis | Rational engineering for enhanced CoQ10 production |
| Plant trans-isoprenyl diphosphate synthases | Diversified prenyl chain synthesis | Evolutionary analysis in plant kingdom |
| Paramecium tetraurelia cis-prenyltransferase subunits | Heteromeric cis-prenyltransferase function | Evolutionary divergence and functional insights |
| Human PDSS1 | Subunit of decaprenyl diphosphate synthase | Mitochondrial ubiquinone biosynthesis; Leigh syndrome spectrum |
| Human PDSS2 | Subunit of decaprenyl diphosphate synthase | Mitochondrial ubiquinone biosynthesis; Leigh syndrome spectrum |
| COQ2 | Para-hydroxybenzoate polyprenyltransferase | Ubiquinone biosynthesis; mitochondrial disease |
| COQ4 | Coenzyme Q biosynthesis complex component | Ubiquinone biosynthesis; mitochondrial disease |
| COQ6 | Coenzyme Q biosynthesis monooxygenase | Ubiquinone biosynthesis; mitochondrial disease |
| COQ8A | Coenzyme Q biosynthesis regulator | Ubiquinone biosynthesis; mitochondrial disease |
| COQ9 | Coenzyme Q biosynthesis complex component | Ubiquinone biosynthesis; mitochondrial disease |
| COQ10A | Coenzyme Q biosynthesis complex component | Ubiquinone biosynthesis; mitochondrial disease |
How Is polyprenyl diphosphate synthase complex Regulated?
Regulation of the polyprenyl diphosphate synthase complex occurs at multiple levels. In Escherichia coli, a subunit of decaprenyl diphosphate synthase stabilizes octaprenyl diphosphate synthase by forming a high-molecular-weight complex, indicating that protein-protein interaction controls enzyme stability. In Saccharomyces cerevisiae, genetic evidence supports a multi-subunit complex in coenzyme Q biosynthesis, suggesting that complex integrity is required for optimal Coq1 function. In Schizosaccharomyces pombe, the heterotetrameric structure of Dps1 and Dlp1 implies that subunit availability and assembly regulate decaprenyl diphosphate synthase activity. In Mycobacterium tuberculosis, decaprenyl diphosphate synthesis is tied to ubiquinone production, and pathway flux may be influenced by respiratory demand. In Corynebacterium glutamicum, rational engineering of non-ubiquinone-containing strains for enhanced coenzyme Q10 production demonstrates that the pathway can be manipulated at the genetic level.
polyprenyl diphosphate synthase complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PDSS1 | Mitochondrial ubiquinone deficiency; Leigh syndrome spectrum | Knockout or point-mutation in human cell lines; rescue with wild-type PDSS1 |
| PDSS2 | Mitochondrial ubiquinone deficiency; Leigh syndrome spectrum | Knockout or point-mutation in human cell lines; CoQ10 supplementation |
| COQ2 | Ubiquinone biosynthesis defect; mitochondrial disease | Knockout in yeast or human cells; complementation assays |
| M. tuberculosis decaprenyl diphosphate synthase | Tuberculosis pathogenesis; antibacterial target | Mycobacterial knockout or knockdown; drug susceptibility testing |
| C. glutamicum prenyltransferase genes | Coenzyme Q10 production | Overexpression or knockout in C. glutamicum; fermentation analysis |
Mitochondrial disease and Leigh syndrome spectrum
Defects in ubiquinone biosynthesis, including steps that depend on the polyprenyl diphosphate synthase complex, can cause mitochondrial disease presentations such as Leigh syndrome spectrum. Leigh syndrome spectrum is a nuclear gene-encoded mitochondrial disorder with heterogeneous genetic causes, and coenzyme Q biosynthesis defects are among the recognized etiologies. Because the polyprenyl diphosphate synthase complex produces the isoprenoid tail of ubiquinone, impaired complex function could reduce ubiquinone levels and compromise respiratory chain function [1,5].
Tuberculosis and antibacterial targeting
In Mycobacterium tuberculosis, decaprenyl diphosphate synthesis is required for ubiquinone production, and the responsible enzyme has been characterized as a potential drug target. Inhibiting the polyprenyl diphosphate synthase complex could disrupt respiratory chain function and oxidative stress defense in mycobacteria, providing a rationale for antibacterial development.
Metabolic engineering and coenzyme Q10 production
Rational engineering of non-ubiquinone-containing Corynebacterium glutamicum for enhanced coenzyme Q10 production demonstrates that the polyprenyl diphosphate synthase pathway can be manipulated for biotechnological benefit. This work highlights the industrial relevance of understanding how polyprenyl diphosphate synthase complexes determine chain length and flux.
From polyprenyl diphosphate synthase complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate subunit abolish polyprenyl diphosphate synthase activity? | CRISPR knockout in human cell lines or yeast deletion strains [1,5] |
| Does a patient variant impair complex assembly or stability? | Point-mutation knock-in in human cells; protein interaction assays |
| Can wild-type gene rescue a ubiquinone deficiency phenotype? | Knock-in or overexpression rescue in knockout background [1,5] |
| Where does the complex localize within mitochondria? | Tagged knock-in with fluorescent or affinity tags; imaging |
| Does overexpression increase coenzyme Q10 production? | Overexpression in Corynebacterium glutamicum |
| Which subunits physically interact? | Tagged knock-in followed by immunoprecipitation or mass spectrometry [2,8] |
How to Study the polyprenyl diphosphate synthase complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotype | Test requirement of PDSS1/PDSS2 for ubiquinone biosynthesis |
| Point-mutation knock-in | Effect of patient variants | Model Leigh syndrome spectrum variants |
| Overexpression | Gain-of-function or rescue | Increase CoQ10 production in C. glutamicum |
| Native gel electrophoresis | High-molecular-weight complex formation | Detect subunit stabilization in E. coli |
| Immunoprecipitation / mass spectrometry | Protein-protein interactions | Identify heterotetramer subunits in S. pombe |
| LC-MS metabolomics | Ubiquinone and precursor levels | Assess pathway flux |
| Enzymatic assay with radiolabeled substrates | Polyprenyl diphosphate synthase activity | Characterize M. tuberculosis enzyme |
| Phylogenetic analysis | Evolutionary relationships | Compare plant and protist prenyltransferases [3,4] |
Genetic and biochemical characterization of subunits
Classical genetic approaches in Saccharomyces cerevisiae and Schizosaccharomyces pombe have been used to identify subunits of the polyprenyl diphosphate synthase complex and to test their requirement for coenzyme Q biosynthesis [5,8]. In Escherichia coli, high-molecular-weight complex formation was demonstrated biochemically, showing that subunit interactions can be detected by native gel electrophoresis or chromatography. In Mycobacterium tuberculosis, decaprenyl diphosphate synthesis was characterized using enzymatic assays with radiolabeled substrates.
CRISPR-based perturbation in human cells
CRISPR knockout and point-mutation knock-in in human cell lines can be used to test whether candidate genes such as PDSS1 or PDSS2 are required for ubiquinone biosynthesis and mitochondrial function. These models allow rescue experiments with wild-type or variant alleles to establish causality. Overexpression of wild-type or mutant subunits can further test dominant-negative or gain-of-function effects.
Metabolic and flux analysis
Measurement of ubiquinone and its precursors by liquid chromatography-mass spectrometry can assess pathway flux through the polyprenyl diphosphate synthase complex. In Corynebacterium glutamicum, rational engineering of non-ubiquinone-containing strains for enhanced coenzyme Q10 production required quantification of CoQ10 and related metabolites. Similar approaches can be applied to human cell models to evaluate the impact of genetic perturbations.
Evolutionary and comparative genomics
Comparative analysis of trans-isoprenyl diphosphate synthases in the plant kingdom and of heteromeric cis-prenyltransferases in Paramecium tetraurelia has revealed evolutionary divergence in prenyltransferase complexes [3,4]. These studies use sequence analysis, phylogenetic reconstruction and functional assays to link genotype to chain-length specificity [3,4].
How CRISPR Can Be Used to Study GO:0032476 polyprenyl diphosphate synthase complex
Knockout
CRISPR knockout of candidate genes such as PDSS1 or PDSS2 in human cell lines can abolish polyprenyl diphosphate synthase complex function and reduce ubiquinone levels, providing a direct test of gene essentiality. In yeast, deletion of COQ1 or DPS1/DLP1 orthologs impairs coenzyme Q biosynthesis and respiratory growth [5,8]. Knockout models are therefore foundational for linking GO:0032476 components to mitochondrial function [1,5].
Point Mutation
Point-mutation knock-in can model patient variants associated with Leigh syndrome spectrum or ubiquinone deficiency, allowing assessment of whether a specific amino acid change impairs complex assembly or catalytic activity. Such models are valuable when complete knockout is lethal or when a hypomorphic allele is suspected.
Knock-in
Tagged knock-in of endogenous subunits with fluorescent or affinity tags enables localization and interaction studies of the polyprenyl diphosphate synthase complex in its native context [1,8]. Knock-in of wild-type alleles into knockout backgrounds can rescue phenotypes and confirm causality.
Overexpression
Overexpression of polyprenyl diphosphate synthase subunits can increase flux toward ubiquinone or coenzyme Q10, as demonstrated in engineered Corynebacterium glutamicum. In human cells, overexpression can test dominant-negative effects of variants or enhance ubiquinone biosynthesis for rescue experiments.
How EDITGENE Supports polyprenyl diphosphate synthase complex Research
Researchers studying polyprenyl diphosphate synthase complex-related genes often need to determine whether a candidate gene is causally involved in ubiquinone biosynthesis, mitochondrial function or bacterial pathogenesis. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbation of GO:0032476 components and their regulators.
Contact EDITGENE today to design your custom CRISPR model for polyprenyl diphosphate synthase complex research.
Frequently Asked Questions About polyprenyl diphosphate synthase complex
What is GO:0032476?
GO:0032476 is the Gene Ontology cellular component term for polyprenyl diphosphate synthase complex, a complex that possesses polyprenyl diphosphate synthase activity involved in the synthesis of the isoprenoid chain of ubiquinone, whose length varies between organisms.
What is the polyprenyl diphosphate synthase complex?
It is a protein complex that produces the polyprenyl diphosphate tail of ubiquinone (coenzyme Q), with chain length varying from six to ten isoprene units depending on the organism [5,7,8].
What genes are involved in the polyprenyl diphosphate synthase complex?
Genes include COQ1 in Saccharomyces cerevisiae, DPS1 and DLP1 in Schizosaccharomyces pombe, decaprenyl diphosphate synthase genes in Mycobacterium tuberculosis, and PDSS1 and PDSS2 in humans [1,5,7,8].
Where is the polyprenyl diphosphate synthase complex located?
In eukaryotes, ubiquinone biosynthesis including polyprenyl diphosphate synthase activity is associated with mitochondria, while in bacteria it occurs in the cell membrane [1,5,7].
What is the function of the polyprenyl diphosphate synthase complex?
Its function is to synthesize the isoprenoid chain of ubiquinone, which is required for respiratory electron transport and oxidative stress defense [1,5,7].
How is the polyprenyl diphosphate synthase complex regulated?
Regulation can occur through subunit stabilization and complex assembly, as shown by the stabilization of octaprenyl diphosphate synthase by a decaprenyl diphosphate synthase subunit in Escherichia coli.
What diseases are associated with polyprenyl diphosphate synthase complex dysfunction?
Dysfunction of ubiquinone biosynthesis, including steps dependent on this complex, is associated with mitochondrial disease such as Leigh syndrome spectrum.
Is the polyprenyl diphosphate synthase complex a drug target?
In Mycobacterium tuberculosis, decaprenyl diphosphate synthesis is required for ubiquinone production and has been characterized as a potential anti-tubercular target.
How can I study the polyprenyl diphosphate synthase complex using CRISPR?
CRISPR knockout, point-mutation knock-in, tagged knock-in and overexpression in human cell lines or microbes can be used to test subunit function, variant effects and pathway flux [1,6,8].
What is the synonym for GO:0032476?
The synonym is decaprenyl diphosphate synthase complex, reflecting the common decaprenyl chain length in organisms such as humans and Mycobacterium tuberculosis [7,8].
Conclusion
GO:0032476, polyprenyl diphosphate synthase complex, is a cellular component term that captures the enzymatic machinery responsible for building the isoprenoid tail of ubiquinone. Its subunit composition and chain-length specificity vary across organisms, from hexaprenyl in budding yeast to decaprenyl in humans and mycobacteria [5,7,8]. The complex is stabilized by subunit interactions and is integrated into coenzyme Q biosynthesis pathways that are essential for respiration and oxidative stress defense [1,2,5]. Research on this complex spans mitochondrial disease, antibacterial drug discovery and metabolic engineering [1,6,7]. CRISPR-based models, including knockout, point-mutation knock-in, tagged knock-in and overexpression, provide powerful tools to dissect subunit function and variant effects [1,6,8]. EDITGENE supports these efforts with custom cell model generation and screening services.
References
- 1. Adam MP et al.. 1993. Nuclear Gene-Encoded Leigh Syndrome Spectrum Overview.. PMID: 26425749
- 2. Cui TZ et al.. 2010. A subunit of decaprenyl diphosphate synthase stabilizes octaprenyl diphosphate synthase in Escherichia coli by forming a high-molecular weight complex.. FEBS Lett 584(4):652-6 PMID: 20051244
- 3. Chen X et al.. 2026. Evolution of trans-isoprenyl diphosphate synthases in the plant kingdom.. Plant Physiol 201(4) PMID: 42025326
- 4. Onysk A et al.. 2026. Evolutionary divergence and functional insights into the heteromeric cis-prenyltransferase of Paramecium tetraurelia.. FEBS J 293(6):1681-1707 PMID: 40847593
- 5. Gin P et al.. 2005. Genetic evidence for a multi-subunit complex in coenzyme Q biosynthesis in yeast and the role of the Coq1 hexaprenyl diphosphate synthase.. J Biol Chem 280(4):2676-81 PMID: 15548532
- 6. Burgardt A et al.. 2022. Rational Engineering of Non-Ubiquinone Containing Corynebacterium glutamicum for Enhanced Coenzyme Q(10) Production.. Metabolites 12(5) PMID: 35629932
- 7. Kaur D et al.. 2004. Decaprenyl diphosphate synthesis in Mycobacterium tuberculosis.. J Bacteriol 186(22):7564-70 PMID: 15516568
- 8. Saiki R et al.. 2003. Fission yeast decaprenyl diphosphate synthase consists of Dps1 and the newly characterized Dlp1 protein in a novel heterotetrameric structure.. Eur J Biochem 270(20):4113-21 PMID: 14519123
